Yinggang Zou

Dr. Yinggang Zou


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
XYXiaoyan Yu
Xiaoyan Yu
QSQing Su
Qing Su
JGJianan Geng
Jianan Geng
HLHui Liu
Hui Liu
YLYumeng Liu
Yumeng Liu
YZYinggang Zou
Yinggang Zou
The present study aimed to investigate the preventive effects of Ginkgo biloba leaf extract (GBE) against extracellular matrix (ECM) accumulation in a streptozotocin (STZ)‑induced rat model of diabetic nephropathy (DN), and to determine its underlying molecular mechanism. In vivo, a rat model of DN was established by intraperitoneal injection of STZ, and the rats were subsequently administered GBE. The results demonstrated that GBE significantly decreased blood glucose, the urine protein excretion rate and ECM accumulation in DN rats. In addition, the development of DN significantly induced tissue transglutaminase (tTG) protein expression, which was detected by immunohistochemistry, western blotting and PCR analyses, while GBE administration decreased tTG expression in the diabetic kidney. In vitro, rat glomerular mesangial cells (HBZY‑1 cells) cultured with high glucose were also treated with GBE. The concentrations of tTG, fibronectin, type IV collagen, transforming growth factor (TGF)‑β and connective tissue growth factor (CTGF) were detected via ELISA. The results demonstrated that GBE notably decreased the concentration of these proteins, and tTG expression was positively associated with TGF‑β. GBE also suppressed tTG expression of high glucose‑treated HBZY‑1 cells in a concentration‑dependent manner. Furthermore, tTG protein expression was detected in high glucose‑treated HBZY‑1 cells transfected with small interfering RNA (siRNA) oligonucleotides against TGF‑β and CTGF to investigate a possible mechanism of GBE‑mediated inhibition of tTG. The results demonstrated that the tTG levels remained unchanged in CTGF siRNA‑transfected cells, but were decreased in the GBE + CTGF siRNA group compared with the control siRNA group, suggesting that tTG may not be regulated by CTGF, and the inhibitory effect of GBE on tTG may not be associated with the direct inhibition of CTGF. However, tTG expression was decreased following the transfection with TGF‑β siRNA, in which levels of tTG were similar compared with both the GBE group and GBE + TGF‑β siRNA group, indicating that tTG may be regulated by TGF‑β, and that the GBE‑induced repression of tTG expression may be associated with the downregulation of TGF‑β. Taken together, the results of the present study suggest that GBE prevented ECM accumulation by suppressing tTG expression in DN, which was predominantly mediated by TGF‑β.

11 March 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
YZYinggang Zou
Yinggang Zou
YXYing Xu
Ying Xu
XCXiaoChen Chen
XiaoChen Chen
LZLian-wen Zheng
Lian-wen Zheng

9 August 2023 in Clinics
Verified
Journal Article
Open access
ZSZhenbo Su
Zhenbo Su
SLSiyao Liu
Siyao Liu
YZYinggang Zou
Yinggang Zou
LSLiang Shan
Liang Shan
MYMiao Yu
Miao Yu
YJYing Jin
Ying Jin
Trastuzumab is the preferred drug for the treatment of breast cancer. However, research on the cellular mechanisms of trastuzumab's potential cardiotoxicity is insufficient. The purpose of this study was to explore the toxic effects and potential mechanism of action of trastuzumab on cardiomyocytes. Human Cardiomyocyte (HCM) viability was assessed using the MTT method. HCM apoptosis was detected using the Hoechst33342/PI Fluorescent staining. The LDH and CK activities of the cell were measured using commercially available LDH and CK assay kits. The expression levels of Notch2, JAK2, STAT3, cleaved caspase 3, bax, and bcl 2 in HCMs were detected using western blotting. The results showed that 250 mg/L trastuzumab induced cardiomyocyte injury and apoptosis, inhibited viability, activated the Notch2 receptor, and inhibited JAK2/STAT3 expression in HCM. Inhibition of Notch2 expression in HCM by targeted siNotch2 transfection reversed the trastuzumab-induced injury and apoptosis, and the expression of JAK2/STAT3 returned to normal levels. Trastuzumab induces Notch2 expression by inhibiting the JAK2/STAT3 pathway of HCMs, promotes cell apoptosis, and causes cardiomyocyteinjury. Notch2 may be a potential target of trastuzumab-inducedmyocardial injury. This experiment reveals the mechanism of trastuzumab-induced cardiotoxicity, providing a theoretical basis for the application of trastuzumab.

18 January 2025 in Heliyon
Verified
Journal Article
Open access
XKXun Kan
Xun Kan
ZZZhenhuan Zhou
Zhenhuan Zhou
LLLianlian Liu
Lianlian Liu
RAReziwanguli Aiskikaer
Reziwanguli Aiskikaer
YZYinggang Zou
Yinggang Zou
Cervical cancer, ranking as the fourth most common cancer in women globally, is closely linked to chronic inflammation resulting from persistent human papillomavirus (HPV) infection. Chronic inflammation mediated by cyclooxygenase (COX) has been identified as a factor in cancer onset and progression, with HPV oncoproteins E6 and E7 inducing COX activation. Nonsteroidal anti-inflammatory drugs (NSAIDs) have demonstrated the capability to significantly inhibit COX activity, playing a crucial preventive and therapeutic role in various tumors. This paper explores the therapeutic value and potential clinical applications of NSAIDs in cervical cancer by examining the mechanistic interactions between HPV and COX and the carcinogenic effects of COX in cervical cancer.

1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JGJianan Geng
Jianan Geng
XYXiaoyan Yu
Xiaoyan Yu
CLChunyu Liu
Chunyu Liu
CSChengbo Sun
Chengbo Sun
MGMenghuan Guo
Menghuan Guo
JYJinghua Yu
Jinghua Yu
Diabetic nephropathy (DN) is a major cause of end‐stage renal disease throughout the world; until now there is no specific drug available. In this work, we use herba artemisiae capillaris extract (HACE) to alleviate renal fibrosis characterized by the excessive accumulation of extracellular matrix (ECM) in rats, aiming to investigate the protective effect of the HACE on DN. We found that the intragastric treatment of high‐dose HACE could reverse the effect of streptozotocin not only to decrease the level of blood glucose and blood lipid in different degree but also further to improve renal functions. It is worth mentioning that the effect of HACE treatment was comparable to the positive drug benazepril. Moreover, we found that HACE treatment could on one hand inhibit oxidative stress in DN rats through regulating enzymatic activity for scavenging reactive oxygen species and on the other hand increase the ECM degradation through regulating the activity of metalloproteinase‐2 (MMP‐2) and the expression of tissue transglutaminase (tTG), which explained why HACE treatment inhibited ECM accumulation. On the basis of above experimental results, we conclude that HACE prevents DN development in a streptozotocin‐induced DN rat model, and HACE is a promising candidate to cure DN in clinic.

16 December 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
SMShuai Ma
Shuai Ma
LZLianwen Zheng
Lianwen Zheng
XZXiaohua Zhuang
Xiaohua Zhuang
MWMin Wang
Min Wang
YZYinggang Zou
Yinggang Zou
The postponement of childbearing age has become a global issue. Factors such as increased work pressures on women and environmental changes have led to a rising incidence and younger onset of premature ovarian insufficiency (POI). POI not only impacts patients’ reproductive function but also heightens the risk of depression, anxiety, cognitive decline, premature mortality, osteoporosis, and cardiovascular disease. Exploring effective prevention and treatment strategies for POI can slow ovarian ageing and safeguard female reproductive health. Microbiome research confirms that most human tissues and organs form dynamic, interactive systems with symbiotic microbes that play a crucial role in female reproductive function. Previous studies on the microbiome and female reproductive health have rarely focused on POI. The proposed ‘Microbiota-Ovary Axis’ aims to establish an integrated regulatory framework. This theoretical model systematically elucidates how microbial signals influence ovarian function through four core pathways: the hypothalamic-pituitary-ovarian (HPO) axis, metabolism and endocrine regulation, immunoregulation, and oxidative stress. Evaluating the efficacy of dietary modifications, probiotics, and microbiota transplantation in animal models and preliminary clinical studies will establish a robust theoretical foundation for developing microbiota-targeted innovative diagnostic and therapeutic strategies for POI, thereby enhancing reproductive health throughout the female lifespan.